logo-vam-390x140

The Value Added Medicines Group is a sector group of Medicines for Europe which aims to optimise, rethink and reinvent medicines based on known molecules and by bringing untapped innovation to improve care delivery.

About us





Value Added Medicines Today

Value Added Medicines contribute to addressing unmet patient needs. Moving from a one-size-fits-all to a much more tailored and patient specific approach, value added medicines are one of the key components of the customisation of healthcare. By answering patients’ unmet needs, they represent a new horizon for those who are currently looking forward to a better quality of life with their treatment.

Read more

Our 5 Pillars

Medicines for Europe's 5 pillars are: Patients, Quality, Value, Sustainability & Partnership.

Read more to see how Value Added Medicines deliver.

Read more

What's new

Latest Data Shows the Need to Promote Biosimilar and Value Added Medicines for Better Health

Read more

Publications

Factsheets
View
Policy
View
Reports
View
Videos
View
Infographics
View

View all

PHOTO GALLERY

20160128 EGA Regulatory and Scientific Affairs Conferenc
EGA Regulatory and Scientific Affairs Conference
28 January 2016
20160127 EGA Pharmacovigilance Conference
20160128 EGA Regulatory and Scientific Affairs Conference
27 January 2016
Launch of the "Regulatory Efficiency Report / 28 September 2015
Launch of the Regulatory Efficiency Report
28 September 2015

View all